Beta(2)-adrenergic receptor regulates cardiac fibroblast autophagy and collagen degradation.

Autophagy is a physiological degradative process key to cell survival during nutrient deprivation, cell differentiation and development. It plays a major role in the turnover of damaged macromolecules and organelles, and it has been involved in the pathogenesis of different cardiovascular diseases. Activation of the adrenergic system is commonly associated with cardiac fibrosis and remodeling, and cardiac fibroblasts are key players in these processes. Whether adrenergic stimulation modulates cardiac fibroblast autophagy remains unexplored. In the present study, we aimed at this question and evaluated the effects of b(2)-adrenergic stimulation upon autophagy. Cultured adult rat cardiac fibroblasts were treated with agonists or antagonists of beta-adrenergic receptors (b-AR), and autophagy was assessed by electron microscopy, GFP-LC3 subcellular distribution, and immunowesternblot of endogenous LC3. The predominant expression of b(2)-ARs was determined and characterized by radioligand binding assays using [(3)H]dihydroalprenolol. Both, isoproterenol and norepinephrine (non-selective b-AR agonists), as well as salbutamol (selective b(2)-AR agonist) increased autophagic flux, and these effects were blocked by propanolol (b-AR antagonist), ICI-118,551 (selective b(2)-AR antagonist), 3-methyladenine but not by atenolol (selective b(1)-AR antagonist). The increase in autophagy was correlated with an enhanced degradation of collagen, and this effect was abrogated by the inhibition of autophagic flux. Overall, our data suggest that b(2)-adrenergic stimulation triggers autophagy in cardiac fibroblasts, and that this response could contribute to reduce the deleterious effects of high adrenergic stimulation upon cardiac fibrosis.

[1]  P. Molinoff,et al.  The pharmacological specificity of beta-1 and beta-2 adrenergic receptors in rat heart and lung in vitro. , 1979, Molecular pharmacology.

[2]  G. Kroemer,et al.  Autophagy in aging, disease and death: the true identity of a cell death impostor , 2009, Cell Death and Differentiation.

[3]  Yasushi Matsumura,et al.  The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress , 2007, Nature Medicine.

[4]  N. Mizushima,et al.  How to Interpret LC3 Immunoblotting , 2007, Autophagy.

[5]  K. Otsu,et al.  The role of autophagy in the heart , 2009, Cell Death and Differentiation.

[6]  Daniel J. Klionsky,et al.  Autophagy in Health and Disease: A Double-Edged Sword , 2004, Science.

[7]  M. Palazzo,et al.  Culture of the terminally differentiated adult cardiac muscle cell: a light and scanning electron microscope study. , 1980, Developmental biology.

[8]  John L Cleveland,et al.  Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes , 2008, Autophagy.

[9]  Eric H. Baehrecke,et al.  Autophagy: dual roles in life and death? , 2005, Nature Reviews Molecular Cell Biology.

[10]  T. Ueno,et al.  LC3 and Autophagy. , 2008, Methods in molecular biology.

[11]  Takeshi Noda,et al.  LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing , 2000, The EMBO journal.

[12]  I. Mercier,et al.  beta-Adrenergic stimulation of rat cardiac fibroblasts promotes protein synthesis via the activation of phosphatidylinositol 3-kinase. , 2001, Journal of molecular and cellular cardiology.

[13]  P. Molenaar,et al.  Modulation of human cardiac function through 4 β-adrenoceptor populations , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.

[14]  K. Weber,et al.  Infarct scar: a dynamic tissue. , 2000, Cardiovascular research.

[15]  P A Insel,et al.  Beta-adrenergic receptors and receptor signaling in heart failure. , 1999, Annual review of pharmacology and toxicology.

[16]  Junying Yuan,et al.  Autophagy in cell death: an innocent convict? , 2005, The Journal of clinical investigation.

[17]  R. Gottlieb,et al.  Autophagy in Ischemic Heart Disease , 2009, Circulation research.

[18]  G. Rousseau,et al.  Propranolol therapy for ectopic beta-adrenergic receptors in adrenal Cushing's syndrome. , 1997, The New England journal of medicine.

[19]  H. Zimmer,et al.  Comitogenic effect of catecholamines on rat cardiac fibroblasts in culture. , 2000, Cardiovascular research.

[20]  C. Schneider,et al.  Calpain is required for macroautophagy in mammalian cells , 2006, The Journal of cell biology.

[21]  Hammond Hk,et al.  Beta-adrenergic receptors and receptor signaling in heart failure. , 1999 .

[22]  L. Brunton,et al.  Identification of G protein-coupled signaling pathways in cardiac fibroblasts: cross talk between G(q) and G(s). , 2000, American journal of physiology. Cell physiology.

[23]  I. LeGrice,et al.  Fibroblast Network in Rabbit Sinoatrial Node: Structural and Functional Identification of Homogeneous and Heterogeneous Cell Coupling , 2004, Circulation research.

[24]  R. Lüllmann-Rauch,et al.  Disturbed cholesterol traffic but normal proteolytic function in LAMP-1/LAMP-2 double-deficient fibroblasts. , 2004, Molecular biology of the cell.

[25]  U. Pfeifer,et al.  Short-term inhibition of cardiac cellular autophagy by isoproterenol. , 1987, Journal of molecular and cellular cardiology.

[26]  F. Colombo,et al.  β‐adrenergic receptor‐mediated DNA synthesis in neonatal rat cardiac fibroblasts proceeds via a phosphatidylinositol 3‐kinase dependent pathway refractory to the antiproliferative action of cyclic AMP , 2003, Journal of cellular physiology.

[27]  S. Tooze,et al.  Microtubules Facilitate Autophagosome Formation and Fusion of Autophagosomes with Endosomes , 2006, Traffic.

[28]  P. Codogno,et al.  Distinct Classes of Phosphatidylinositol 3′-Kinases Are Involved in Signaling Pathways That Control Macroautophagy in HT-29 Cells* , 2000, The Journal of Biological Chemistry.

[29]  G. D. De Meyer,et al.  Autophagy in the cardiovascular system. , 2009, Biochimica et biophysica acta.

[30]  Å. Gustafsson,et al.  beta-adrenergic stimulation of rat cardiac fibroblasts enhances induction of nitric-oxide synthase by interleukin-1beta via message stabilization. , 2000, Molecular pharmacology.

[31]  Per O. Seglen,et al.  Methods for Monitoring Autophagy from Yeast to Human , 2007, Autophagy.

[32]  L. Delbridge,et al.  Angiotensin II Type 2 Receptor Antagonizes Angiotensin II Type 1 Receptor–Mediated Cardiomyocyte Autophagy , 2009, Hypertension.

[33]  C. Long,et al.  The cardiac fibroblast, another therapeutic target for mending the broken heart? , 2002, Journal of molecular and cellular cardiology.

[34]  W. Koch,et al.  β-Adrenergic Receptor-mediated DNA Synthesis in Cardiac Fibroblasts Is Dependent on Transactivation of the Epidermal Growth Factor Receptor and Subsequent Activation of Extracellular Signal-regulated Kinases* , 2002, The Journal of Biological Chemistry.

[35]  M. Bahro,et al.  Short-term stimulation by propranolol and verapamil of cardiac cellular autophagy. , 1987, Journal of molecular and cellular cardiology.

[36]  I. Mercier,et al.  β -Adrenergic Stimulation of Rat Cardiac Fibroblasts Promotes Protein Synthesis via the Activation of Phosphatidylinositol 3-kinase , 2001 .

[37]  S. Lavandero,et al.  β-adrenergic receptors in rat mammary gland , 1985 .

[38]  Robert Clarke,et al.  Guidelines for the use and interpretation of assays for monitoring autophagy , 2012 .

[39]  S. Jamieson,et al.  Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. , 1986, Circulation research.

[40]  P. Insel,et al.  Angiotensin II Enhances Adenylyl Cyclase Signaling via Ca2+/Calmodulin , 2003, Journal of Biological Chemistry.

[41]  B. Rothermel,et al.  Autophagy in load-induced heart disease. , 2008, Circulation research.

[42]  S. Ball,et al.  Chronic beta2-adrenergic receptor stimulation increases proliferation of human cardiac fibroblasts via an autocrine mechanism. , 2003, Cardiovascular research.